Clinical trial Recruiting at 1 site Interventional Ages 3 to 17

Using eye-tracking technology to help children with severe communication disabilities

Official title: Augmentative Alternative Communication Intervention Delivered Via Eye-tracking Technology

Run by IRCCS Centro Neurolesi Bonino Pulejo · NCT05808478 · Data updated 2026-11-12

This study is testing a new eye-tracking communication tool to help children with severe communication disabilities express themselves better and improve their quality of life.

Quick facts

Study typeInterventional
Ages3 Years to 17 Years
SexAll
Enrollment30 (estimated)
SponsorIRCCS Centro Neurolesi Bonino Pulejo
Academic / other
Locations1 site (Messina)
StatusRecruiting
StartedJanuary 22, 2022
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedApril 11, 2023
Trial IDNCT05808478 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 3 to 17 with neuropsychiatric conditions that result in complex communication needs.

Probably not a fit

Patients outside the age range of 3 to 17 or those unable to control eye movements may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to develop an Augmentative and Alternative Communication (AAC) intervention utilizing eye-tracking technology for children aged 3 to 17 with severe communication disabilities. The study focuses on enhancing communication skills through the analysis of eye movements, allowing patients to better express themselves and interact with their environment. Additionally, it seeks to understand the psychosocial impact of this technology on the quality of life for both patients and their families. The intervention will involve both AAC methods and eye-tracking systems to support effective communication.

Why it matters

Potential benefit: If successful, this intervention could significantly improve communication abilities and quality of life for children with severe communication disabilities.

How similar studies have gone: Other studies have shown promise in using technology for augmentative communication, but this specific approach with eye-tracking is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* aged between 3 and 17 years affected by neuropsychiatric pathology presenting complex communication needs
* Control of eye motility and visual fixation
* ability to maintain position in front of the monitor
* availability of at least one member of the family nucleus to participate in the therapeutic process
* cognitive skills appropriate to the task such as being able to recognize images and being able to memorize procedures necessary to use the various basic functions

Exclusion Criteria:

* age not between 3 and 17 years
* difficulty in controlling ocular motility and visual fixation
* the unavailability of at least one member of the family nucleus to participate in the therapeutic process
* impaired cognitive skills on the task such as being able to recognize pictures and being able to memorize procedures necessary to use various basic functions

Where it's running

  • IRCCS Neurolesi Bonino Pulejo
    Messina, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.